Conshohocken, PA (PRWEB) January 21, 2014
The transition to a services and outcome focus is underway in healthcare. Digital medicine provides the premier platform for healthcare and pharmaceutical industry constituents to share information, form partnerships, and meaningfully advance important issues. To help pharmaceutical companies better understand how digital medicine will redefine the pharmaceutical business model, Pharmica will host its “Pharma 3.0 – The Digital Medicine Era” conference in Conshohocken, PA on April 30th & May 1st, 2014.
“We are very eager to hear Gil’s presentation at our upcoming digital medicine conference,” said Matt Hendricks, Partner with Pharmica Consulting. “Gil is the President, Founder, and Chief Science Officer of Segterra and brings with him a wealth of information from his various positions with MIT, the Weizmann Institute, and several systems biology/computational biology companies.”
“Gil will discuss how physicians can use digital medicine to expose a patient’s biomarkers that identify genetic, biochemical, and physiological information. This allows the patient accurate understanding of their current health status. Personalized health is about using this information from the biomarkers to keep healthy people healthy.”
Those interested in learning more about Pharmica Consulting and upcoming forums or service offerings can visit http://www.pharmicaconsulting.com/services/ . To request additional information, please contact Greg Cohee at 215-579-1650 or Matt Kiernan at 610-945-4364.
About Pharmica Consulting:
Pharmica Consulting, one of the Life sciences Industry leading consulting firms, provides a variety of offerings designed to help pharmaceutical and biotech clients achieve true operational excellence. Consultants at Pharmica invest the time needed to truly understand a client’s specific challenges and tailor solutions to help them create a more profitable business environment. Pharmica Consulting knows how to build effective strategies - and deliver against those strategies as promised.